sequana

Sequana Medical receives CE-mark approval

on 30/10/2012 13:27
Sequana Medical receives CE-mark approval for the use of its alfapump® system in cancer patients with malignant ascites
Read more

Sequana Medical’s ALFApump® System proves to be a safe and efficacious

on 20/04/2012 12:20
Data presented at the International Liver Disease Meeting demonstrated that the ALFApump System significantly decreases the need for Large Volume Paracentesis and can reduce hospital visits
Read more

Sequana Medical receives CE Mark Approval for the ALFApump™ System and adds Key Executive to Team

on 13/07/2011 16:34
New technology expands treatment options for patient with refractory ascites due to liver cirrhosis. Dr. Farzana Malik joins as Vice President of Market Access and Reimbursement.
Read more

Capricorn Health-tech Fund makes first investment

on 11/04/2011 16:59
Following the first close of Capricorn Health-tech Fund in December 2010, Capricorn Venture Partners announced today its investment in NovaShunt AG, based in Zug, Switzerland.
Read more